m research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.
FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:Page: 1 2 3 4 5 6 Related biology technology :1
. Sterilization Market (Medical Devices, Pharmaceutical, Healthcare, Food Applications), Equipments & Contract Services - Global Forecast To 20172
. Nanotechnologies and bio-inspiration for healthcare, communication, more will highlight SPIE Microtechnologies3
. GNS Healthcare, Dana-Farber and Mount Sinai Collaborate to Build Computer Model of Multiple Myeloma4
. Healthcare, Regulatory and Reimbursement Landscape - Australia5
. Bayer CropScience and MS Technologies Receive Approval for Balance GT Soybean Technology in the United States6
. ACRES Launches Global Clinical Research Network Technology Platform7
. American Museum of Agriculture Changes Name to Reflect Bayer CropScience’s Agriculture Tradition and World-Class Technology8
. Public Offerings of Common Stock, Financial Results, and Significant Progress in Key Development Programs - Research Report on BioCryst, Exelixis, Idenix, Puma Biotechnology, and Halozyme9
. Sanguine BioSciences Announces Distribution Partnership with AMS Biotechnology10
. Easy, Reliable Viscosity Measurements via Viscometer-Rheometer-on-a-Chip (VROC) Technology11
. Biotech & BioPharma Professionals: CA Board of Pharmacy Executive, Virginia Herold, to Deliver Keynote at BSMA Annual Biotechnology Conference Oct 8-9